Healthcare provider profile · identity verified

Justin Silverstrim

Physician Assistant · WILLIAMSPORT, PA · NPI 1225647548

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Famotidine	Famotidine	246	42
Lorazepam	Lorazepam	168	44
Tramadol Hcl	Tramadol Hcl	135	38
Oxycodone Hcl	Oxycodone Hcl	127	25
Levothyroxine Sodium	Levothyroxine Sodium	111	26
Potassium Chloride	Potassium Chloride	104	32
Eliquis	Apixaban	93	20
Gabapentin	Gabapentin	68	14
Risperidone	Risperidone	67	suppressed
Mirtazapine	Mirtazapine	66	14
Atorvastatin Calcium	Atorvastatin Calcium	65	19
Duloxetine Hcl	Duloxetine Hcl	64	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	54	27
Omeprazole	Omeprazole	53	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	suppressed
Pregabalin	Pregabalin	49	suppressed
Trazodone Hcl	Trazodone Hcl	47	suppressed
Cephalexin	Cephalexin	46	19
Buspirone Hcl	Buspirone Hcl	42	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	23
Sertraline Hcl	Sertraline Hcl	41	suppressed
Ondansetron Hcl	Ondansetron Hcl	40	35
Lisinopril	Lisinopril	38	14
Amlodipine Besylate	Amlodipine Besylate	37	13
Metoprolol Succinate	Metoprolol Succinate	35	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	35	18
Warfarin Sodium	Warfarin Sodium	35	suppressed
Levofloxacin	Levofloxacin	34	22
Finasteride	Finasteride	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	11
Lacosamide	Lacosamide	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Clonazepam	Clonazepam	29	suppressed
Furosemide	Furosemide	29	13
Morphine Sulfate	Morphine Sulfate	29	19
Metoprolol Tartrate	Metoprolol Tartrate	28	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Sodium Chloride	0.9 % Sodium Chloride	26	14
Xarelto	Rivaroxaban	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	15
Sucralfate	Sucralfate	24	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	23	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	21
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Benztropine Mesylate	Benztropine Mesylate	20	suppressed
Sulfasalazine	Sulfasalazine	20	suppressed
Ketoconazole	Ketoconazole	19	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Losartan Potassium	Losartan Potassium	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Baclofen	Baclofen	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	13
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Amiloride Hcl	Amiloride Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Lidocaine Hcl	Lidocaine Hcl	15	suppressed
Metformin Hcl	Metformin Hcl	15	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Gemtesa	Vibegron	14	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Prednisone	Prednisone	13	suppressed
Topiramate	Topiramate	13	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Lagevrio (Eua)	Molnupiravir	12	11
Memantine Hcl Er	Memantine Hcl	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Oxazepam	Oxazepam	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error